To conclude, in SNPs of FBW7 and its substrate genes, the mTOR rs1057079 AG genotype could be used to predict the clinical response and to achieve better mPFS of patients with advanced ESCC treated with TP regimen as first-line chemotherapy. This evidence concerns the gene MTOR and esophageal squamous cell carcinoma.